Three Ways To Accelerate From Trial To Market

Moving from pre-IND to IND involves de-risking the process by preparing for FDA interactions with a focused pre-IND meeting request and package, ensuring meaningful feedback. Selecting the right Contract Research Organization (CRO) is essential for smooth progression, necessitating a careful evaluation of performance, technology, and budget considerations. CRO partnerships must be based on stringent criteria to avoid unforeseen challenges. Data integrity should also be a priority from the outset to prevent a lack of clarity or other issues. Engaging experienced consultants, like Halloran, who provide end-to-end solutions across regulatory and clinical development phases, is key to navigating these hurdles effectively. By adopting a structured, expert-driven approach, companies can optimize their chances of reaching the market efficiently and with fewer setbacks.